278650 — HLB BioStep Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩110bn
Enterprise Value
KR₩103bn
Revenue
KR₩74bn

Annual balance sheet for HLB BioStep Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,393	97,045	70,358	46,842	43,343
Net Total Accounts Receivable
Net Total Receivables	10,153	10,148	6,629	12,610	12,707
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31,178	112,424	79,413	62,478	60,606
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39,867	39,626	40,678	52,094	37,936
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	94,626	172,187	171,714	168,329	155,575
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,582	12,775	64,682	46,285	47,978
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	30,038	101,909	70,124	56,455	59,303
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	64,587	70,278	101,590	111,874	96,272
Total Liabilities & Shareholders' Equity	94,626	172,187	171,714	168,329	155,575
Total Common Shares Outstanding